Inhibition of the JAK/STAT pathway with ruxolitinib overcomes cisplatin resistance in non-small-cell lung cancer NSCLC
Crossref DOI link: https://doi.org/10.1007/s10495-014-1030-z
Published Online: 2014-09-12
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hu, Yuan
Hong, Yin
Xu, YuanJie
Liu, Ping
Guo, Dai-Hong
Chen, Yibang
Text and Data Mining valid from 2014-09-12